XOMA Royalty (XOMA) Net Equity Issued and Repurchased (2010 - 2019)

XOMA Royalty (XOMA) reported Net Equity Issued and Repurchased of $22.0 million for Q4 2019, up 489.04% on a YoY basis from $3.7 million in Q4 2018, and up 489.04% sequentially from $3.7 million in Q4 2018.

XOMA Royalty (XOMA) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends

XOMA Royalty (XOMA) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $22.0 million in Q4 2019.

  • For the quarter ending Q4 2019, Net Equity Issued and Repurchased rose 489.04% year-over-year to $22.0 million; the trailing twelve-month figure through Sep 2020 stood at $25.7 million (up 585.0% YoY), and the FY2025 full-year result was $323000.0, changed N/A from the prior year.
  • Net Equity Issued and Repurchased grew to $22.0 million in Q4 2019, from $3.7 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $22.0 million in Q4 2019 to a low of -$189000.0 in Q4 2015.
  • A 5-year average of $4.4 million and a median of $134000.0 in 2015 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased slumped 100.5% in 2015 and soared 489.04% in 2019, its largest moves.
  • Tracing XOMA's Net Equity Issued and Repurchased over 5 years: stood at -$189000.0 in 2015, then surged by 106.35% to $12000.0 in 2016, then slumped by 541.67% to -$53000.0 in 2017, then jumped by 7141.51% to $3.7 million in 2018, then soared by 489.04% to $22.0 million in 2019.
  • Business Quant data shows XOMA's Net Equity Issued and Repurchased at $22.0 million in Q4 2019, $3.7 million in Q4 2018, and $22000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 21.98 Mn
Dec 31, 2019 21.98 Mn
Dec 31, 2018 3.73 Mn
Dec 31, 2018 3.73 Mn
Jun 30, 2018 22,000.00
Jun 30, 2018 22,000.00
Mar 31, 2018 2.31 Mn
Mar 31, 2018 2.31 Mn
Sep 30, 2017 -53,000.00
Sep 30, 2017 -53,000.00
Mar 31, 2017 20.07 Mn
Mar 31, 2017 20.07 Mn
Dec 31, 2016 12,000.00
Dec 31, 2016 12,000.00
Dec 31, 2015 -189,000.00
Dec 31, 2015 -189,000.00
Sep 30, 2015 149,000.00
Sep 30, 2015 149,000.00
Jun 30, 2015 77,000.00
Jun 30, 2015 77,000.00